Rephonic
Artwork for Vanguards of Healthcare by Bloomberg Intelligence

Vanguards of Healthcare by Bloomberg Intelligence

Bloomberg
Artificial Intelligence
Clinical Trials
Biotech
AI In Healthcare
HIV
Biotechnology
FDA
Venture Capital
Home Care
Type 2 Diabetes
Oncology
Medicaid
Health Systems
Prep
AI Technology
Cancer Treatment
Insulin Delivery Systems
FDA Approval
Long-Acting Treatments
Healthcare Revenue Cycle

Vanguards of Healthcare is a series of exclusive conversations with management teams and thought leaders discussing changes on the forefront of the industry, including innovations in medical products and technologies, advances in clinical research, new service models, wellness and regulations.

PublishesWeeklyEpisodes146Founded3 years ago
Number of ListenersCategories
InvestingHealth & FitnessBusiness

Listen to this Podcast

Artwork for Vanguards of Healthcare by Bloomberg Intelligence

Latest Episodes

“Forty percent of patients in this country alone in the first year drop out [of current retinal disease treatments] and every one of those patients ends up going blind. By far the most expensive disease in the world is blindness and the reason for th... more

“We’re seeing it already to much more of a preventative proactive monitoring to find these things earlier in the patient journeys and help eliminate and prevent and reduce downstream costs,” IRhythm Technologies CEO Quentin Blackford discusses the op... more

Based on long-term results, “the effectiveness of that nanosecond pulse electric field begins to look as if it is a step function ahead of first generation PFA,” Pulse Biosciences CEO Paul LaViolette says, referring to the next stage of pulsed-field... more

“I think this is going to be the most eventful ASCO for biotech in a while,” says Dr. Roderick Wong, founder of RTW Investments, referring to the annual meeting of the American Society of Clinical Oncology. Wong joins Bloomberg Intelligence analyst S... more

Key Facts

Accepts Guests
Contact Information
Podcast Host
Number of Listeners
Find out how many people listen to this podcast per episode and each month.

Similar Podcasts

People also subscribe to these shows.

Biotech Hangout
Biotech HangoutDaphne Zohar, Josh Schimmer, Brad Loncar, Tim Opler and more
Invest Like the Best with Patrick O'Shaughnessy
Invest Like the Best with Patrick O'ShaughnessyColossus | Investing & Business Podcasts

Recent Guests

Quentin Blackford
CEO of IRhythm
IRhythm
Episode: IRhythm Pushes a Proactive Approach to Monitoring
Paul LaViolette
CEO, Pulse Biosciences
Pulse Biosciences
Episode: Pulse Biosciences Brings Differentiated Nanosecond Technology to PFA
Rod Wong
Founder of RTW, a health care investor
RTW
Episode: RTW’s Rod Wong on Biotech’s Revival and the Global Shift
Neil Hattangadi
CEO and co-founder of Cortica
Cortica
Episode: Cortica’s Plan to Bring Value-Based Care to Autism
Chris Garabedian
CEO of Sarepta Therapeutics (history discussed) and founder of Xontogeny; investor with Perceptive Xontogeny Ventures
Xontogeny; Perceptive Xontogeny Ventures
Episode: Xontogeny's Case for Drug Developers Over Storytellers
Matt Gline
CEO of Roivant
Roivant
Episode: Roivant’s Playbook for Finding Value Others Miss in Biotech
Sami Inkinen
CEO and co-founder of Virta Health
Virta Health
Episode: Virta Health’s Push to Reverse Metabolic Disease at Scale
Bob Segert
Chairman and CEO of Athenahealth
Athenahealth
Episode: Athenahealth's Strategic Reset, Push for Speed in Ambulatory Care
Alex Zhavoronkov
Founder and CEO of Insilico Medicine
Insilico Medicine
Episode: Inside Insilico Medicine’s AI Strategy and Lilly Breakthrough

Hosts

Matt Henriksson
Medical Technology Analyst at Bloomberg Intelligence (and related roles across Bloomberg Intelligence).
Jonathan Palmer
Healthcare analyst at Bloomberg Intelligence with experience across hospital systems and care delivery.
Sam Fazeli
Senior Pharmaceuticals/Biopharma Analyst at Bloomberg Intelligence with focus on biotech and drug development.

Chart Rankings

How this podcast ranks in the Apple Podcasts, Spotify and YouTube charts.

Talking Points

Recent interactions between the hosts and their guests.

IRhythm Pushes a Proactive Approach to Monitoring
Q: Could you share updates on the MCT product and FDA collaboration?
The company is working closely with the FDA to transition from the old gateway to a mobile gateway, addressing cybersecurity concerns, and aims for first-half 2027 launch with a new MCT device that could capture several hundred million dollars in incremental revenue.
IRhythm Pushes a Proactive Approach to Monitoring
Q: What is the commercial strategy to scale up care upstream and reach more patients?
IRhythm is moving prescribing up the care pathway into primary care, leveraging large health networks and innovative channel partners, and integrating with electronic health records like Epic Aura to streamline workflows and reduce the burden on physicians while expanding preventive care.
IRhythm Pushes a Proactive Approach to Monitoring
Q: How has the market for cardiac monitoring evolved, and where does IRhythm fit in the ecosystem?
The market is consolidating around end-to-end solutions that combine device, AI-enabled analysis, and backend interpretation, with IRhythm positioned to own the end-to-end pathway and dominate longer-duration monitoring, which aligns with physician demand for a comprehensive service rather than isolated software or hardware.
Pulse Biosciences Brings Differentiated Nanosecond Technology to PFA
Q: How do you view the role of IP and your catheter and generator design in differentiating nanosecond PFA from competitors?
We have a large, defensible IP estate covering the generator, catheter interfaces, and delivery of nanosecond pulsed electric fields, which together create a proprietary platform. This moat supports a unique combination of pulse duration and energy delivery that underpins product differentiation and potential market leadership.
Pulse Biosciences Brings Differentiated Nanosecond Technology to PFA
Q: What are the key clinical milestones you've observed so far, and how do they impact the timeline to regulatory approval?
Early data show rapid, high-quality lesion formation and strong workflow advantages. The pivotal IDE is the next major milestone, designed to validate 90-96% endpoints for AFib and other arrhythmias, with enrollment beginning and a projected PMA submission timeline in early 2028, assuming timely completion of enrollment and regulatory review.

Audience Metrics

Listeners, social reach, demographics and more for this podcast.

Listeners per Episode
Gender Skew
Location
Interests
Professions
Age Range
Household Income
Social Media Reach

Frequently Asked Questions About This Podcast

What is This Podcast about and what kind of topics does it cover?

This show features in-depth conversations with senior healthcare executives, investors, and scientists who shape medical devices, biopharma, digital health, and health services. Episodes consistently explore market dynamics, regulatory and R&D strategies, and the evolving business models powering healthcare innovation, from AI-enabled diagnostics to novel device platforms and reimbursement considerations. Notable strengths include access to top-tier industry leaders, data-driven perspectives on commercialization and policy, and a focus on practical implications for patients, providers, and investors. The format tends to blend technical depth with strategic storytelling, making it useful for professionals seeking insights into where healthca... more

Where can I find podcast stats for this podcast?

Rephonic provides a wide range of podcast stats for this podcast. We scanned the web and collated all of the information that we could find in our comprehensive podcast database. See how many people listen to this podcast and access YouTube viewership numbers, download stats, audience demographics, chart rankings, ratings, reviews and more.

How many listeners does this podcast get?

Rephonic provides a full set of podcast information for three million podcasts, including the number of listeners. View further listenership figures for this podcast, including podcast download numbers and subscriber numbers, so you can make better decisions about which podcasts to sponsor or be a guest on. You will need to upgrade your account to access this premium data.

What are the audience demographics for this podcast?

Rephonic provides comprehensive predictive audience data for this podcast, including gender skew, age, country, political leaning, income, professions, education level, and interests. You can access these listener demographics by upgrading your account.

How many subscribers and views does this podcast have?

To see how many followers or subscribers this podcast has on Spotify and other platforms such as Castbox and Podcast Addict, simply upgrade your account. You'll also find viewership figures for their YouTube channel if they have one.

Which podcasts are similar to this podcast?

These podcasts share a similar audience with this podcast:

1. Biotech Hangout
2. The Readout Loud
3. Invest Like the Best with Patrick O'Shaughnessy
4. The Long Run with Luke Timmerman
5. BioCentury This Week

How many episodes of this podcast are there?

this podcast launched 3 years ago and published 146 episodes to date. You can find more information about this podcast including rankings, audience demographics and engagement in our podcast database.

How do I contact this podcast?

Our systems regularly scour the web to find email addresses and social media links for this podcast. We scanned the web and collated all of the contact information that we could find in our podcast database. But in the unlikely event that you can't find what you're looking for, our concierge service lets you request our research team to source better contacts for you.

Where can I see ratings and reviews for this podcast?

Rephonic pulls ratings and reviews for this podcast from multiple sources, including Spotify, Apple Podcasts, Castbox, and Podcast Addict.

View all the reviews in one place instead of visiting each platform individually and use this information to decide if a show is worth pitching or not.

How do I access podcast episode transcripts for this podcast?

Rephonic provides full transcripts for episodes of this podcast. Search within each transcript for your keywords, whether they be topics, brands or people, and figure out if it's worth pitching as a guest or sponsor. You can even set-up alerts to get notified when your keywords are mentioned.

What guests have appeared on this podcast?

Recent guests on this podcast include:

1. Quentin Blackford
2. Paul LaViolette
3. Rod Wong
4. Neil Hattangadi
5. Chris Garabedian
6. Matt Gline
7. Sami Inkinen
8. Bob Segert

To view more recent guests and their details, simply upgrade your Rephonic account. You'll also get access to a typical guest profile to help you decide if the show is worth pitching.

Find and pitch the right podcasts

We help savvy brands, marketers and PR professionals to find the right podcasts for any topic or niche. Get the data and contacts you need to pitch podcasts at scale and turn listeners into customers.
Try it free for 7 days